<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-ZQ09E0BH/2463e06a-3b9b-4bee-9082-748d31e68516/PDF"><dcterms:extent>143 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-ZQ09E0BH/4c259382-323a-491b-8d08-0a934b8993f4/TEXT"><dcterms:extent>17 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2022-2025"><edm:begin xml:lang="en">2022</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-ZQ09E0BH"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-UCB4A42Q" /><dcterms:issued>2025</dcterms:issued><dc:creator>Čuturič, Lidija</dc:creator><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">str. 8-10</dc:format><dc:identifier>COBISSID_HOST:248494083</dc:identifier><dc:identifier>ISSN:2820-5014</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-ZQ09E0BH</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Fakulteta za farmacijo, ŠSSFD</dc:publisher><dcterms:isPartOf xml:lang="sl">Placebo</dcterms:isPartOf><dc:subject xml:lang="en">acne</dc:subject><dc:subject xml:lang="sl">akne</dc:subject><dc:subject xml:lang="en">atopic dermatitis</dc:subject><dc:subject xml:lang="sl">atopijski dermatitis</dc:subject><dc:subject xml:lang="sl">Koža</dc:subject><dc:subject xml:lang="sl">kožne bolezni</dc:subject><dc:subject xml:lang="sl">kožni rak</dc:subject><dc:subject xml:lang="sl">luskavica</dc:subject><dc:subject xml:lang="en">psoriasis</dc:subject><dc:subject xml:lang="en">skin cancer</dc:subject><dc:subject xml:lang="en">skin diseases</dc:subject><dc:subject xml:lang="sl">Vitamin D</dc:subject><dc:subject xml:lang="sl">vitiligo</dc:subject><dcterms:temporal rdf:resource="2022-2025" /><dc:title xml:lang="sl">Pomen vitamina D pri kožnih obolenjih| splošno o dermatoveneroloških boleznih|</dc:title><dc:description xml:lang="sl">Vitamin D is important for skin health as it plays a role in many skin diseases. The main source of vitamin D is sunlight, but it can also be obtained through diet. Vitamin D deficiency is often associated with various skin problems such as psoriasis, atopic dermatitis, vitiligo, acne and skin cancer. Vitamin D helps to regulate the immune system and reduce inflammation, so supplementation can have a positive effect on the course of inflammatory skin conditions such as atopic dermatitis and acne. Studies have also shown that vitamin D can reduce the risk of skin cancer by influencing signalling pathways associated with carcinogenesis. Vitamin D analogues are also effective in the topical treatment of certain conditions, namely psoriasis, vitiligo and dermal fibrosis, by affecting cell proliferation and differentiation, stimulating melanocyte renewal and reducing inflammation. A comprehensive understanding of the action of vitamin D could contribute to the development of new therapeutic approaches for the treatment of skin diseases</dc:description><dc:description xml:lang="sl">Vitamin D je pomemben za zdravje kože, saj ima vlogo pri številnih kožnih boleznih. Glavni vir vitamina D je sončna svetloba, pridobimo ga lahko tudi s prehrano. Pomanjkanje vitamina D je pogosto povezano z različnimi kožnimi težavami, kot so luskavica, atopijski dermatitis, vitiligo, akne in kožni rak. Vitamin D prispeva k uravnavanju imunskega sistema in zmanjševanju vnetnih procesov, zato lahko njegovo dodajanje pozitivno vpliva na potek vnetnih kožnih obolenj, kot so atopijski dermatitis in akne. Študije so pokazale tudi, da lahko vitamin D zmanjša tveganje za nastanek kožnega raka, saj vpliva na signalne poti, povezane s kancerogenezo. Analogi vitamina D pa so učinkoviti tudi pri lokalni terapiji določenih stanj, in sicer luskavice, vitiliga in kožne fibroze, saj vplivajo na celično proliferacijo in diferenciacijo, spodbujajo obnovo melanocitov ter zmanjšujejo vnetje. Celovito razumevanje delovanja vitamina D bi lahko prispevalo k razvoju novih terapevtskih pristopov pri zdravljenju kožnih bolezni</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-ZQ09E0BH"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-ZQ09E0BH" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-ZQ09E0BH/2463e06a-3b9b-4bee-9082-748d31e68516/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:dataProvider xml:lang="en">National and University Library of Slovenia</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-ZQ09E0BH/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-ZQ09E0BH" /></ore:Aggregation></rdf:RDF>